Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria

English | 正體中文 | 简体中文 | Items with full text/Total items : 45346/58522 (77%)
Visitors : 2505557 Online Users : 158

RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.

Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer

TMUIR > College of Medicine > Graduate Institute of Clinical Medicine > Periodical Article > Item 987654321/3103

Please use this identifier to cite or link to this item: http://libir.tmu.edu.tw/handle/987654321/3103

Title:	Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria
Authors:	劉興璟 Chen WCChiang BL;Liu HE;Leu SJ;Lee YL
Contributors:	臨床醫學研究所
Date:	2008
Issue Date:	2009-08-21 16:58:16 (UTC+8)
Abstract:	Background: Patients with chronic ordinary urticaria (CU) are divided into two groups: 30-50% have chronic autoimmune urticaria, and the remainder have chronic idiopathic urticaria. CD4+CD25+ regulatory T (Treg) cells play critical roles in maintaining peripheral tolerance and preventing autoimmunity, but the characteristics of Treg cells have not yet been defined in CU. Objective: To identify whether CD4+ Tcells play an important immunoregulatory role in the etiology of CU, we determined the frequencies and functions of circulating CD4+CD25+ and CD4+CD25- Tcells in CU patients and healthy control subjects, with special focus on the characteristics of CD4+CD25+ T cells. Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from CU and healthy controls in this study. The frequency of CD4+CD25+ T cells in PBMCs was detected by flow cytometry. The expression levels of forkhead box P3 (FOXP3) and transforming growth factor-β (TGF-β) in CD4+CD25+ Tcells were detected by real-time PCR. Furthermore, the suppressive function of CD4+CD25+ Tcells was analyzed. Additionally, the Th1/Th2 cytokine secretory profile in mitogen-stimulated CD4+CD25- Tcells was measured by ELISA. Results: An increased frequency of CD4+CD25+ T cells was observed in CU patients (n = 19) compared to control subjects (n = 7). No significant difference was detected in the expression levels of FOXP3 or TGF-β between CU patients (n = 14) and control subjects (n = 7). Strikingly, the suppressive capacity of CD4+CD25+ Treg cells from 2 of 5 CU patients was partially defective. We also found that cytokine production from CD4+CD25- Tcells was significantly reduced in CU patients (n = 9) compared to healthy donors in = 11). Conclusions: Our data demonstrate that CD4+CD25+ and CD4+CD25- Tcells in PBMCs exhibit defective functions in CU patients.
Relation:	Journal of dermatological science.(51):121-130.
Data Type:	article
Appears in Collections:	[臨床醫學研究所] 期刊論文

Files in This Item:

File	Description	Size	Format
全文.txt		0Kb	Text	208	View/Open
摘要.pdf		35Kb	Adobe PDF	127	View/Open

著作權聲明 Copyright Notice

本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。
The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.
瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。
By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.
本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。
TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

Loading...